CE(16:2)

Metabolite details

Identifier

OYOAMRKUJRRRSM-FYALRKDYSA-N

InChI Key

OYOAMRKUJRRRSM-FYALRKDYSA-N

IUPAC name

Preferred name

CE(16:2)

INN name

—

Synonym

(1S,2R,5S,10S,11S,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadec-7-en-5-yl (9E,12E)-hexadeca-9,12-dienoate

ChEBI

CHEBI:89566

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Hfq Regulates Efflux Pump Expression and Purine Metabolic Pathway to Increase the Trimethoprim Resistance in Aeromonas veronii
• Industrial by-products as a novel circular source of biocompatible extracellular vesicles
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium

Observed in differential profiles

• Wild_type_vs_hfq
• Brewer_Spend_Yeast_vs_Whey
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• wild_type_vs_patA_deletion